FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

3 letters match. Newest first.

  1. RemedyRepack, Inc.

    RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.

    High risk
  2. Centrient Pharmaceuticals India Private Limited

    Centrient Pharmaceuticals India's API plant drew FDA CGMP violations, including weak records and unproven beta-lactam contamination testing.

    High risk
  3. Laboratorio Pharma International SRL

    FDA warns Laboratorio Pharma International over CGMP failures, unapproved GELAZUL, misbranding, and incomplete beta-lactam separation.

    High risk